Skip to main content
OpenTrials
Completed

NCT Number: NCT02815085

RecoverLINK Technology Pilot for HF Patients

The primary objective is to examine feasibility of incorporating RecoverLINK into the standard of care as a function of (i) user engagement, (ii) user satisfaction, and (iii) workflow efficiency. As secondary objectives, the investigators will collect preliminary data to examine the association between patient engagement with the RecoverLINK app and (i) changes in patient knowledge and behavior, and (ii) hospital readmission(s) at 30, 60, and 90-day time periods post-enrollment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Heart Failure Cardiovascular Diseases Heart Diseases

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Mount Sinai Hospital

New York, 10029, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Heart failure (HF) patients with a rapid follow up appointment scheduled at the Mount Sinai HF clinic
  • English-speaking
  • With either access to (i) an iOS smart device or (ii) wifi at-home

Exclusion criteria

Patients meeting any of the following criteria:

  • A heart transplant
  • A mechanical circulatory support (MCS) device
  • An altered mental status
  • Serious co-morbidities (as identified by Mount Sinai team)
  • Cognitive impairments (as identified by Mount Sinai team)
  • Inability to use technology (as identified by Mount Sinai team)

Treatment and study plan

RecoverLINK technology

Other

HF patients will receive the RecoverLINK app upon study enrollment for 30-days. The Mount Sinai HF care team will interact with patients via the RecoverLINK cloud-based system during this period

Primary outcomes

  1. User engagement: # symptom surveys completed/30 days

    Time frame: 30 days

  2. User satisfaction: Percent patients report "satisfied" via post-program survey

    Time frame: 30 days

  3. Workflow efficiency: mean/median time to resolution of patient alerts

    Time frame: 30 days

Secondary outcomes

  1. Mean difference in pre/post SCHIFI score

    Time frame: 30 days

  2. Hospital admission

    Time frame: 30, 60, 90 days

Sponsors and collaborators

Lead sponsor

RecoverLINK

Industry

Collaborators

  • Digital Health Marketplace (previously Pilot Health Tech NYC)
  • Mount Sinai Hospital, New York

Registry information

Official study title

Pilot to Assess Feasibility of Using RecoverLINK Technology to Supplement Outpatient Care for Heart Failure Patients

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Jun 28, 2016
Registry last updated
Aug 31, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.